Colfax Corporation (CFX)
NYSE: CFX
· Real-Time Price · USD
39.06
-1.53 (-3.77%)
At close: Apr 05, 2022, 6:00 AM
Colfax Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|
| Fabrication Technology Revenue | 4.86B | 607.5M |
| Fabrication Technology Revenue Growth | +699.37% | n/a |
| Medical Technology Revenue | 2.85B | n/a |
| Medical Technology Revenue Growth | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|
| Foreign Revenue | 2.29B | 3.53B | 3.37B |
| Foreign Revenue Growth | -35.06% | +4.63% | n/a |
| United States Revenue | 1.56B | 1.1B | 836.64M |
| United States Revenue Growth | +42.46% | +31.22% | n/a |
Operating Expense Breakdown
| Period Ending | Apr 4, 2025 | Dec 31, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 31, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Dec 31, 2015 | Sep 25, 2015 | Jun 26, 2015 | Mar 27, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 269.02M | 257.71M | 228.43M | 264.1M | 255.69M | 211.01M | 204.25M | 207.88M | 207.16M | 208.59M | 182.19M | 225.48M | 369.39M | 351.67M | 334.42M | 337.56M | 305.72M | 281.42M | 278.06M | 235.73M | 291.3M | 285.86M | 290.5M | 307.94M | 318.14M | 218.07M | 194.83M | 204.78M | 200.52M | 198.79M | 181.84M | 208.22M | 206.05M | 197.8M | 199.5M | 213.55M | 214.39M | 232.84M | 237.25M | 222.63M | 213.23M |
| Selling, General, and Administrative Revenue Growth | +4.39% | +12.82% | -13.51% | +3.29% | +21.17% | +3.31% | -1.75% | +0.35% | -0.68% | +14.49% | -19.20% | -38.96% | +5.04% | +5.16% | -0.93% | +10.41% | +8.64% | +1.21% | +17.96% | -19.08% | +1.90% | -1.60% | -5.66% | -3.21% | +45.89% | +11.93% | -4.86% | +2.13% | +0.87% | +9.32% | -12.67% | +1.06% | +4.17% | -0.85% | -6.58% | -0.39% | -7.93% | -1.86% | +6.57% | +4.41% | n/a |
| Research and Development Revenue | 28.53M | 23.95M | 20.49M | 23.48M | 23.38M | 18.32M | 19.9M | 18.92M | 18.19M | 14.72M | 15.6M | 15.66M | 14.84M | 27.4M | 20.2M | 21.3M | 19.9M | 19.2M | 16.8M | 14.1M | 18.5M | 17M | 16.3M | n/a | n/a | 34.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39.3M | n/a | n/a | n/a | 41.5M | n/a | n/a | n/a |
| Research and Development Revenue Growth | +19.11% | +16.89% | -12.73% | +0.44% | +27.61% | -7.95% | +5.20% | +3.99% | +23.55% | -5.60% | -0.40% | +5.52% | -45.83% | +35.64% | -5.16% | +7.04% | +3.65% | +14.29% | +19.15% | -23.78% | +8.82% | +4.29% | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |